DoD FY13 Prostate Cancer Idea Development Award - Grants.gov ...

---

---

The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 05/13/2013 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.

If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.

Document Type:	Grants Notice
Funding Opportunity Number:	W81XWH-13-PCRP-IDA
Opportunity Category:	Discretionary
Posted Date:	May 13, 2013
Creation Date:	May 13, 2013
Original Closing Date for Applications:	Oct 02, 2013 ??
Current Closing Date for Applications:	Oct 02, 2013 ??
Archive Date:	Nov 01, 2013
Funding Instrument Type:	Cooperative Agreement Grant
Category of Funding Activity:	Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:	32
Estimated Total Program Funding:	$17,300,000
Award Ceiling:	$0
Award Floor:	$0
CFDA Number(s):	12.420 ?--? Military Medical Research and Development
Cost Sharing or Matching Requirement:	No

Eligible Applicants

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
?

Additional Information on Eligibility:

Agency Name

Dept. of the Army -- USAMRAA

Description

The PCRP Idea Development Award mechanism was first offered in FY97. Since then, 5,748 Idea Development Award applications have been received, and 1,029 have been recommended for funding. The Idea Development Award supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. Although groundbreaking research often involves a degree of risk, applications should be based on a sound scientific rationale that is established through logical reasoning and/or critical review and analysis of the literature. Due to this award?s emphasis on innovation, the presentation of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Research deemed innovative may represent a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that is an incremental advance upon published data is not considered innovative. The PCRP seeks applications from the wide spectrum of basic, population-based, translational, and clinical research. In addition, applicants are expected to address at least one of the PCRP focus areas and are highly encouraged to address one of the PCRP overarching challenges. If the proposed project does not address any of the overarching challenges, the application should include a description to justify how the project will nevertheless address a critical need in the field of prostate cancer research and/or patient care. New Investigator Option: The FY13 Idea Development Award mechanism encourages applications from investigators in the early stages of their careers. The New Investigator Option is designed to allow applicants early in their faculty appointments, or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer- and programmatically reviewed in separate groups. PIs using the New Investigator Option are strongly encouraged to strengthen their applications through collaboration with investigators experienced in prostate cancer research and/or possessing other relevant expertise. It is the responsibility of the PI to describe how collaboration will augment his or her expertise to best address the research question. All applicants for the New Investigator Option must meet specific eligibility criteria as described in Section I.C., Eligibility Information.

Link to Additional Information

If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk
301-682-5507 CDMRP Help Desk

Synopsis Modification History

There are currently no modifications for this opportunity.

?

Source: http://www.grants.gov/search/search.do?mode=VIEW&oppId=234313

Meteor Hits Russia Dorner Manifesto Valentines Day Quotes nerlens noel Mark Balelo Anne Stringfield paczki